When people take inosine by mouth it is changed in the body to make a chemical called uric acid. Uric acid acts like an antioxidant and might protect cells in the brain.
People use inosine for Parkinson disease, multiple sclerosis (MS), athletic performance, and many other conditions, but there is no good scientific evidence to support these uses.
Uses & Effectiveness
We currently have no information for INOSINE overview.
Special Precautions and Warnings
Pregnancy and breast-feeding: There isn't enough reliable information to know if inosine is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.
Gout: Taking inosine might increase levels of uric acid. This might make gout worse in some people.
Medications for gout (Antigout Drugs) interacts with INOSINE
Inosine increases levels of uric acid. High levels of uric acid might make gout worse. Taking inosine along with antigout drugs might reduce the effects of these drugs.
Be cautious with this combination
You Might Also Like
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.